# ESLICARBAZEPINE ACETATE
> **ANDA211247** · Abbreviated New Drug Application (Generic) · Sponsor: SPH ZHONGXI PHARM · Approved 2025-11-03
## Drug
- **FDA Application Number:** ANDA211247
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESLICARBAZEPINE ACETATE
- **Generic name:** Eslicarbazepine Acetate
- **Active ingredients:** ESLICARBAZEPINE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SPH ZHONGXI PHARM
- **First approval:** 2025-11-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211247)
---
*MORVS · CC0 1.0*